Bolt Biotherapeutics Current Cash

Bolt Biotherapeutics (BOLT) currently reports a current cash of $13M as of June 2026. That compares with $9.6M in the prior-year period — up 33.9% year over year. Use the charts on this page to explore Bolt Biotherapeutics's current cash history and peer comparisons.

Bolt Biotherapeutics's current cash increased from $9.6M to $13M — a 33.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bolt Biotherapeutics reported $13M in current cash as of June 2026. That compares with $9.6M in the prior-year period — up 33.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bolt Biotherapeutics, and consider following BOLT for alerts when major investors trade the stock.

Bolt Biotherapeutics is classified in the Healthcare sector. On current cash, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BOLT with unrelated industries.